ELOXX PHARMACEUTICALS INC (ELOX)

US29014R2022 - Common Stock

3.82  -0.23 (-5.68%)

After market: 2.8 -1.02 (-26.7%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2023-6-30)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
0.000.000.000.000.00
Operating Expenses
22.79M34.42M66.02M29.44M50.56M
Research and Development
14.00M23.73M45.57M14.59M25.84M
Selling, General, and Administrative Expenses
8.79M10.69M20.45M14.85M24.71M
Operating Income
-22.79M-34.42M-66.02M-29.44M-50.56M
Interest Income/Expense
-1.28M-1.72M-1.25M-1.12M-320.00K
Other Income/Expense
N/A77.00KN/AN/AN/A
Non Recurring Items
N/A0.00540.00K-4.02M0.00
Income Before Taxes
-24.40M-36.06M-66.73M-34.58M-50.87M
Income Tax
N/AN/AN/A0.000.00
Net Income
-24.40M-36.06M-66.73M-34.58M-50.87M
EBITDA
-22.73M-34.34M-65.90M-29.37M-50.47M
 
Per Share Data
EPS Diluted Total Ops
-11.22-16.65-38.15-0.86-1.34
Non GAAP EPS
-11.36-16.52-26.80-28.40-53.60
 
Statistics
Profit Margin
N/AN/AN/AN/AN/A
Operating Profit Margin
N/AN/AN/AN/AN/A

All data in USD

Charts